Fertility rates and birth outcomes after ChAdOx1 nCoV-19 (AZD1222) vaccination

Lancet. 2021 Nov 6;398(10312):1683-1684. doi: 10.1016/S0140-6736(21)02282-0. Epub 2021 Oct 21.

Authors

Kushalinii Hillson¹, Sue Costa Clemens², Shabir A Madhi³, Merryn Voysey¹, Andrew J Pollard¹, Angela M Minassian⁴; Oxford COVID Vaccine Trial Group

Affiliations

¹ Oxford Vaccine Group, University of Oxford, Oxford, OX3 7LE, UK.
² Department of Paediatrics, University of Oxford, Oxford, OX3 7LE, UK.
³ University of the Witwatersrand, Johannesburg, South Africa.
⁴ Oxford Vaccine Group, University of Oxford, Oxford, OX3 7LE, UK; Jenner Institute, University of Oxford, Oxford, OX3 7LE, UK. Electronic address: angela.minassian@ndm.ox.ac.uk.

No abstract available

Publication types

Letter

MeSH terms

Birth Rate*
COVID-19 / prevention & control*
COVID-19 Vaccines / administration & dosage*
ChAdOx1 nCoV-19
Female
Humans
Pandemics
Pregnancy
Pregnancy Outcome*
SARS-CoV-2

Substances

COVID-19 Vaccines
ChAdOx1 nCoV-19